Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

disclosure of large shareholding – Investinor Direkte AS

Reference is made to the stock exchange announcement by poLight ASA the "Company") on 28 April 2023 regarding the results of the fully underwritten rights issue of 12,918,660 shares (the "Rights Issue"). In connection with the Rights Issue, the Company will also issue a total of 1,291,858 new shares to the underwriters in the Rights Issue to settle the underwriters' claim for underwriting commission. Consequently, the Company will have 14,210,518 shares issued and outstanding following completion of the Rights Issue. After the issuance of the new shares in connection with the Rights

poLight ASA: Mandatory notifications of trade – allocations to primary insiders in Rights Issue

Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a fully underwritten rights issue of 12,918,660 new shares ("Offer Shares") in the Company (the "Offer Shares"), raising gross proceeds of NOK 135 million (the "Rights Issue"). Reference is further made to the mandatory notifications of trade by certain members of the Company's management on 17 April 2023. Following the allocation of Offer Shares in the Rights Issue on 28 April 2023, the following Offer Shares have been allocated to members of the Company's Management: ·

CLS announces enrollment completion of initial phase of CLS-sponsored glioblastoma laser ablation study with the ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital

Lund, Sweden –Clinical Laserthermia Systems AB (publ) (CLS), today announced that all five patients have been safely treated in the clinical study at Skåne University Hospital  (SUS).The aim of the study is to evaluate safety and feasibility of using minimally invasive MRgLITT in brain, for ablation of tumor tissue in patients diagnosed with glioblastoma. In the study, the team at Skåne University Hospital utilized CLS’s latest thermal therapy product branded ClearPoint Prism™ Neuro Laser Therapy System 

Asetek A/S – Last day of trading in the Preemptive Rights

Aalborg, 2 May 2023. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the stock exchange announcements by Asetek A/S (the "Company" or "Asetek") on 18 April and 24 April 2023 regarding the start of the subscription period in the fully underwritten rights issue of 71,166,667 new shares in the Company (the "New Shares") at a subscription price of NOK 3 per share, raising gross proceeds of NOK 213,500,001

Elkem ASA – Ex dividend NOK 6.00 today

Oslo, 2 May 2023 The shares in Elkem ASA will be traded ex dividend of NOK 6.00 as of today, 2 May 2023. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact:Odd-Geir LyngstadVP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.com Fredrik NormanVP Corporate Communications & Public AffairsTel: +47 918 66 567Email: fredrik.norman@elkem.com About Elkem:Elkem is one of the world’s leading providers of advanced silicon-based

ODAC vote on Lynparza combo in prostate cancer

2 May 2023 Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer The Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has recognised a favourable benefit risk profile for AstraZeneca and MSD's Lynparza (olaparib) plus abiraterone and prednisone or prednisolone for the treatment of adult patients with BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC) based on the PROpel Phase III trial. The Committee voted 11 to 1, with 1 abstaining, that the indication should be

Proact achieves Rubrik Authorized Support Partner status

Europe's leading independent cloud services and data centre provider Proact has had a strong partnership of several years with Rubrik, a leading Zero Trust Data Security™ company. Proact’s high level of expertise in delivering exceptional support for Rubrik's products and services has now resulted in the company gaining Rubrik Authorized Support Partner status in Sweden.To become a Rubrik Authorized Support Partner (RASP), Proact must maintain the same certifications and rigorous training as Rubriks own support engineers. As a RASP, Proact will act as the first point of contact for joint

Autoliv presents new safety innovations at Auto Shanghai 2023

(Shanghai, China, May 2, 2023) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, presented several new safety solutions at the Shanghai Automobile Industry Exhibition 2023. The new safety solutions include an integrated cockpit, a zero-gravity seat, and the Star steering wheel. The new products are designed to provide safety, comfort, and an improved driving experience.Our development teams constantly challenge and redefine the standards of mobility safety. Autoliv is committed to deliver new safety solutions driven by global automotive market

ZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023

The shareholders in Zinzino AB (publ.) are hereby invited to the annual general meeting on Wednesday, 31 May 2023, at 1.30 pm on the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 13.15. It is the company's ambition to webcast the meeting in order to be able to take part in the meeting remotely. RIGHT TO PARTICIPATE IN THE GENERAL MEETING Shareholders who wish to participate in the annual general meeting shall. i. partly be entered in the share register kept by Euroclear Sweden AB as of Tuesday, 23 May 2023, and ii. and, on the other hand,

TIE Kinetix Issued Share Capital

TIE Kinetix, listed at Euronext Amsterdam, announces the issuance of shares following the payment of its FY 2023 interim dividend.For payment of the FY 2023 interim dividend of € 0.50 per share, shareholders could opt for payment of the dividend either in cash or in shares.Approximately 62% of outstanding shares were registered for payment of stock dividend. Today, on the dividend payment date, the Company has issued 32,475 new shares for payment of the stock dividend. Shares have been emitted without issuance of a prospectus based on the exemption of Article 1, paragraph 4, sub h of the

Invitation to presentation of Balder’s Interim report January-March 2023

On 11 May at 08:00 (CET), Fastighets AB Balder will be publishing its Interim report for January to March 2023. The report will be published at balder.se . On the same day, at 08:45, Balder’s CEO Erik Selin and CFO Ewa Wassberg will be holding an online presentation and telephone conference that analysts, investors, the media and other stakeholders are welcome to attend. The presentation will be held in English, and during the telephone conference there will be an opportunity for representatives from the financial market to ask

Implantica Announces 100[th] RefluxStop™ Procedure Completed in a Single Center of Excellence in Germany

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, congratulates the hospital Klinikum Friedrichshafen for completing 100 RefluxStop™ procedures. The innovative RefluxStop™ therapy offers a unique mechanism of action compared to traditional anti-reflux surgical procedures, reducing many of the common side effects associated with these procedures.Priv.-Doz. Dr. Thorsten G. Lehmann, MHBA - Center Director and Chief Physician of the Clinics for General and Visceral Surgery Friedrichshafen & Tettnangis, a leading anti-reflux expert in Germany,

Exel Composites' Business Review Q1-Q3 2022: Revenue EUR 28.8 million and adjusted operating profit EUR 0.0 million

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      2 MAY 2023 at 09:00 EETQ1 2023 in brief · Order intake decreased by 30.0% to EUR 26.3 million (Q1 2022: 37.6) · Revenue decreased by 15.7% to EUR 28.8 million (34.2) · Operating profit declined to EUR -0.3 million (0.0), operating profit margin -1.0% (0.1%) · Adjusted operating profit declined to EUR 0.0 million (2.2), operating profit margin 0.0% (6.4%) · Earnings per share amounted to EUR -0.18 (0.00) Updated guidance for the full year 2023 Considering the current market environment Exel Composites has adjusted

Scania interim report January-March 2023

Strong performance despite continuing macroeconomic and geopolitical uncertainty. Transport activity remained high in general, as did demand.  · Scania’s net sales grew by 42 percent to SEK 45.8 billion (32.2) · Operating margin was 13.5 percent (7.5) · Cash flow amounted to SEK 4.9 billion (-1.2) in Vehicles and Services · Vehicle deliveries increased by 36 percent to 22,626 · Deliveries of Zero Emission Vehicles (ZEV) increased by over 300 percent from low levels to 74 (24)Overall global truck demand remains at a high level in Scania’s key markets, with the exception of

Zinzino AB (publ.) cancels warrants that have not been exercised

Zinzino AB (publ.) announces that the company has started the process of canceling all 800,000 warrants in the 2021-01 series with an exercise price of SEK 140 and which expires on 2026-05-31. No warrants in the series have been subscribed to date, whereby the board wishes to create space for the upcoming annual general meeting of the company to decide on new, more attractive incentive programs for key personnel in the external distributor organization and for senior executives in the group. The scrapping means that the maximum dilution, if all warrants held by warrant holders in the

Flex LNG – Invitation to the Q1 2023 presentation

Hamilton, BermudaMay 2, 2023 Flex LNG Ltd (“Flex LNG” or the “Company”) will release its preliminary financial results for the first quarter of 2023 on Tuesday May 16, 2023, on or about 07:00 CEST (1:00 a.m. EST). In connection with the earnings release, a live video webcast will be held at 15:00 CEST (9:00 a.m. EST) on the same day. In order to attend, use the following link to register and watch the webcast: https://events.webcast.no/viewer-registration/Pn9ZYoK6/register 

Insider information, profit warning: Exel Composites lowers its guidance for the full year 2023

EXEL COMPOSITES PLC      INSIDE INFORMATION      2 MAY 2023 at 08:45 EETExel Composites lowers its guidance for the full year 2023. Exel Composites expects that revenue will decrease and adjusted operating profit will decrease significantly in 2023 compared to 2022. Previously Exel Composites expected that revenue in 2023 will be at last year’s level and adjusted operating profit will increase compared to 2022.   The change in guidance is due to lower-than-expected revenue and adjusted operating profit in the first quarter of 2023 and weaker-than-expected short-term demand outlook. In

DNB Bank ASA – Completion of the merger with Sbanken and transfer of debtor positions under existing bonds

Reference is made to the previous stock exchange notices published by DNB Bank ASA (“DNB”) with respect to the merger with DNBs wholly owned subsidiary Sbanken ASA (“Sbanken”), including the stock exchange notice dated 10 November 2022, where DNB announced that the Board of Directors of both DNB and Sbanken have approved the merger plan. The merger has today been registered in the Norwegian Registry of Business Enterprises and is, consequently, effective in accordance with section 13-17, cf. section 13-24 of the Norwegian Public Limited Companies Act.  DNB has assumed all assets, rights

Reminder: HANZA invites to Q1 presentation on May 3

HANZA AB (publ) will publish its interim report for the first quarter of 2023 on May 3 at approx. 7.30 am CET. In connection with the report, HANZA invites investors, shareholders and media to a combined audiocast and conference call at 11.00 am CET the same day.The report will be presented by Erik Stenfors, CEO, and Lars Åkerblom, CFO.The presentation will be held in English. Link to webcast: https://ir.financialhearings.com/hanza-q1-2023 Participate via teleconference: Register via this link  to participate

Lagercrantz acquires Fireco Ltd

Lagercrantz has acquired 95% of the shares of Fireco Ltd, based in Brighton, United Kingdom. Fireco is a leading manufacturer of fire door retainers well suited for buildings that need enhanced fire protection.Fireco, designs, engineers and manufactures fire door hardware. The major product line is the Dorgard® product, a fire door retainer. The products are largely sold through wholesalers, distributors, and installers. Typical end-customers are schools, care homes, hospitals, public and commercial buildings that require enhanced fire protection. United Kingdom is Fireco’s largest

Fortum’s Board of Directors has reassessed Leadership Team’s long-term incentives – Leadership Team voluntarily waives incentives with delivery in 2024

FORTUM CORPORATION STOCK EXCHANGE RELEASE 2 MAY 2023 AT 8:30 EEST Release category: Other information disclosed according to the rules of the stock exchange Following a discussion at Fortum’s Annual General Meeting on 13 April 2023, the AGM decided to reject the advisory decision on the remuneration report for the company’s governing bodies for 2022. Fortum’s newly appointed Board of Directors has now reassessed the implementation of the remuneration restrictions set forth in the Bridge financing arrangement with the Finnish State last fall. According to the terms of the

Employees at SLP acquire warrants corresponding to 1.75 million shares

Within the incentive program authorized at the 2023 annual general meeting, all permanent employees at SLP have acquired warrants corresponding to a total of 1.75 million shares. This adds SEK 6.8 million to the company.SLP's management team, which consists of three people, has acquired warrants corresponding to approx. 850,000 shares. Other employees, nine people, have acquired warrants corresponding to approx. 900,000 shares. Each warrant entitles the holder to subscribe for one new share of series B in the company during the period from and including 1 May 2026 to and including 31 May

Panoro Energy – Trading Statement and Operations Update

Oslo, 2 May 2023 – Panoro Energy ASA (“Panoro” or the “Company”) today provides an update in advance of its Q1 2023 results which are scheduled for release on 24 May 2023. Information contained within this release is unaudited and may be subject to further review and amendment. Current group working interest production is strong at approximately 8,500 bopd, in line with expectations, following the key milestone of first oil at the Hibiscus Ruche Phase I development offshore Gabon on the Dussafu Marin Permit in early April and the acquisition by Panoro of the 40 percent minority interest

Altris secures €4.8 million (SEK 50M) of bridge financing and gears up management with new CEO and CFO

Altris, the Swedish sodium-ion battery developer, has secured SEK 50M of bridge financing from its current owners and appointed Björn Mårlid as its new CEO and Christer Berguvist as new CFO, as the company moves ahead with its commercialisation journey.Since its foundation in 2017, Altris has been on a rapid journey to develop components, such as Prussian White cathodes, electrolytes, battery cells and production blueprints, for market-leading sodium-ion batteries. Following its €9.6 million (SEK 100M) Series A Funding in 2022, Altris has secured a €4.8 million (SEK 50M) bridge financing

There are no items matching the current filter
There are no more items matching the current filter
Back to top